Interstitial Lung Disease as an Adverse Drug Reaction in Japan: Exploration of Regulatory Actions as a Basis for High Reporting

INTRODUCTION: Increased post-marketing reports of interstitial lung disease in Japan have been recognized. An understanding of its regional groundings can be important for the global pharmacovigilance community. OBJECTIVE: The objective of this study was to explore the correlation between high rates...

Descripción completa

Detalles Bibliográficos
Autores principales: Iwasa, Eiko, Fujiyoshi, Yu, Kubota, Yuki, Kimura, Ryota, Chandler, Rebecca E., Taavola, Henric, Norén, G. Niklas, Wakao, Rika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7575479/
https://www.ncbi.nlm.nih.gov/pubmed/32617874
http://dx.doi.org/10.1007/s40264-020-00968-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7575479/
https://www.ncbi.nlm.nih.gov/pubmed/32617874
http://dx.doi.org/10.1007/s40264-020-00968-7

Ejemplares similares